Sleep Disorders Trial, Recruiting NCT06505109 Sponsor: Erasmus Medical Center Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06505109
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are taking part in a cardiac rehabilitation (heart recovery) program at one of the study centres, for any heart-related reason covered by Dutch medical guidelines
  • People aged 18 or older
  • People who are able to read and communicate in Dutch
  • People who are experiencing sleep problems or stress, as shown by a score above 5 on a standard sleep quality questionnaire (PSQI) or a score above 13 on a standard stress questionnaire (PSS-10)
  • People who have given their written agreement to take part in the study

Who may not be able to join:

  • People with serious psychiatric (mental health), cognitive (thinking or memory), or physical conditions that would prevent them from taking part in cardiac rehabilitation
  • People who are currently receiving treatment for sleep problems, stress, or any other type of behavioural therapy at the start of the study, or who are expected to begin such treatment within the first 6 months — if that treatment could interfere with the study program. Note: people who have previously been diagnosed with a sleep disorder may still be considered eligible if they are still experiencing sleep or stress problems, unless they fall under the condition above. People using an ongoing treatment (such as a CPAP breathing machine for sleep apnoea) that has kept their sleep and stress stable for the 3 months before their heart event may still be considered eligible (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +31107033190

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Erasmus Medical Center
Registry
ClinicalTrials.gov
Start date
28 August 2024
Est. completion
1 January 2027

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Objectively assessed sleep duration; Objectively assessed sleep-onset latency; Objectively assessed wake after sleep onset; Objectively assessed sleep efficiency; Self-reported sleep quality; Perceived stress level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov